• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.慢病毒介导的血管紧张素-(1-7)过表达减轻缺血诱导的心脏病理生理学改变。
Exp Physiol. 2011 Sep;96(9):863-74. doi: 10.1113/expphysiol.2011.056994. Epub 2011 Jun 17.
2
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.适度的心脏选择性血管紧张素 II 型受体过表达可保护心脏功能免受缺血性损伤。
Exp Physiol. 2012 Jan;97(1):89-101. doi: 10.1113/expphysiol.2011.060673. Epub 2011 Oct 3.
3
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.血管紧张素转化酶 2/血管生成素-(1-7)/Mas 轴赋予心肺对肺纤维化和肺动脉高压的保护作用。
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1065-72. doi: 10.1164/rccm.200912-1840OC. Epub 2010 Jun 25.
4
Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).有氧运动训练引起的左心室肥厚涉及调节性 MicroRNAs、血管紧张素转换酶-血管紧张素 II 的减少以及血管紧张素转换酶 2-血管紧张素 (1-7) 的协同调节。
Hypertension. 2011 Aug;58(2):182-9. doi: 10.1161/HYPERTENSIONAHA.110.168252. Epub 2011 Jun 27.
5
Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology.血管紧张素转换酶2在心脏中的过表达可保护心脏免受缺血诱导的病理生理影响。
Hypertension. 2008 Mar;51(3):712-8. doi: 10.1161/HYPERTENSIONAHA.107.100693. Epub 2008 Feb 4.
6
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.二脒那嗪增强血管紧张素转换酶 2 活性并减轻缺血性心脏病理生理学改变。
Hypertension. 2013 Oct;62(4):746-52. doi: 10.1161/HYPERTENSIONAHA.113.01337. Epub 2013 Aug 19.
7
Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.依那普利可减轻心肌梗死大鼠心室功能障碍晚期血管紧张素转换酶2的下调。
Hypertension. 2006 Oct;48(4):572-8. doi: 10.1161/01.HYP.0000237862.94083.45. Epub 2006 Aug 14.
8
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.心肌梗死后,血管紧张素-(1-9)基因治疗可保留左心室收缩功能。
J Am Coll Cardiol. 2016 Dec 20;68(24):2652-2666. doi: 10.1016/j.jacc.2016.09.946.
9
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.血管紧张素转换酶2-血管紧张素(1-7)-Mas受体轴可减轻心肌梗死后的心脏重塑和纤维化。
Mol Med Rep. 2017 Aug;16(2):1973-1981. doi: 10.3892/mmr.2017.6848. Epub 2017 Jun 23.
10
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.血管紧张素转换酶2的缺失会加速心肌梗死后适应性不良的左心室重塑。
Circ Heart Fail. 2009 Sep;2(5):446-55. doi: 10.1161/CIRCHEARTFAILURE.108.840124. Epub 2009 Jun 15.

引用本文的文献

1
Circulating angiotensin-converting enzyme 2 concentration is associated with acute kidney injury and mortality in sepsis.循环血管紧张素转换酶2浓度与脓毒症患者的急性肾损伤及死亡率相关。
PLoS One. 2025 Aug 29;20(8):e0330668. doi: 10.1371/journal.pone.0330668. eCollection 2025.
2
Angiotensin-(1-7) modulates gut-bone marrow axis in diabetes.血管紧张素 -(1 - 7)调节糖尿病中的肠 - 骨髓轴。
Biochem Pharmacol. 2025 Jul 15;241:117168. doi: 10.1016/j.bcp.2025.117168.
3
Cardiovascular Disease in Post-Acute COVID-19 Syndrome: A Comprehensive Review of Pathophysiology and Diagnosis Approach.急性 COVID-19 综合征后心血管疾病:病理生理学与诊断方法的综合综述
Rev Cardiovasc Med. 2023 Jan 13;24(1):28. doi: 10.31083/j.rcm2401028. eCollection 2023 Jan.
4
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles.用于心肌梗死的mRNA疗法:靶点与递送载体综述
Front Bioeng Biotechnol. 2022 Nov 25;10:1037051. doi: 10.3389/fbioe.2022.1037051. eCollection 2022.
5
Mechanistic studies of MALAT1 in respiratory diseases.MALAT1在呼吸系统疾病中的机制研究。
Front Mol Biosci. 2022 Nov 7;9:1031861. doi: 10.3389/fmolb.2022.1031861. eCollection 2022.
6
Alamandine alleviated heart failure and fibrosis in myocardial infarction mice.阿拉曼丁可减轻心肌梗死后心力衰竭和纤维化。
Biol Direct. 2022 Sep 27;17(1):25. doi: 10.1186/s13062-022-00338-6.
7
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.一项关于血管紧张素1-7(TXA-127)治疗重症新型冠状病毒肺炎的随机、安慰剂对照、双盲试验性研究。
Crit Care. 2022 Jul 28;26(1):229. doi: 10.1186/s13054-022-04096-9.
8
The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia.冠状病毒受体血管紧张素转换酶2(ACE2)在分化气道上皮细胞中的动态特性。
BBA Adv. 2022;2:100044. doi: 10.1016/j.bbadva.2022.100044. Epub 2022 Feb 12.
9
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.各种缺氧条件下的替代 RAS:从心肌梗死到 COVID-19。
Int J Mol Sci. 2021 Nov 26;22(23):12800. doi: 10.3390/ijms222312800.
10
Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.SARS-CoV-2 诱导的 ACE2 失调在 COVID-19 严重程度中起着关键作用。
Biomed Pharmacother. 2021 May;137:111363. doi: 10.1016/j.biopha.2021.111363. Epub 2021 Feb 5.

本文引用的文献

1
Effects of ACE2 inhibition in the post-myocardial infarction heart.心肌梗死后心脏中 ACE2 抑制的影响。
J Card Fail. 2010 Sep;16(9):777-85. doi: 10.1016/j.cardfail.2010.04.002. Epub 2010 May 23.
2
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.血管紧张素转化酶 2/血管生成素-(1-7)/Mas 轴赋予心肺对肺纤维化和肺动脉高压的保护作用。
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1065-72. doi: 10.1164/rccm.200912-1840OC. Epub 2010 Jun 25.
3
Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.循环而非心脏血管紧张素-(1-7)可刺激心肌梗死后的心脏保护作用。
Circ Heart Fail. 2010 Mar;3(2):286-93. doi: 10.1161/CIRCHEARTFAILURE.109.905968. Epub 2010 Jan 26.
4
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.血管紧张素-(1-7)可改善果糖喂养大鼠的心脏重构,并抑制心脏中的促生长途径。
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1003-13. doi: 10.1152/ajpheart.00803.2009. Epub 2010 Jan 8.
5
Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.在心脏中携带产生血管紧张素 -(1 - 7)融合蛋白的转基因大鼠中,异丙肾上腺素诱导的心脏纤维化的减轻。
Ther Adv Cardiovasc Dis. 2010 Apr;4(2):83-96. doi: 10.1177/1753944709353426. Epub 2010 Jan 5.
6
Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue.重组腺相关病毒 9 血清型对大鼠心脏组织的选择性趋向性。
J Gene Med. 2010 Jan;12(1):22-34. doi: 10.1002/jgm.1404.
7
Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.白细胞介素-6和肿瘤坏死因子-α作为心力衰竭的生化标志物:与B型利钠肽的直接临床比较
J Cardiovasc Med (Hagerstown). 2009 Oct;10(10):758-64. doi: 10.2459/JCM.0b013e32832ce8e2.
8
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.血管紧张素转换酶2作为预防肺动脉高压治疗靶点的证据。
Am J Respir Crit Care Med. 2009 Jun 1;179(11):1048-54. doi: 10.1164/rccm.200811-1678OC. Epub 2009 Feb 26.
9
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.内源性血管紧张素 -(1 - 7)可减轻糖尿病高血压大鼠心脏缺血诱导的功能障碍。
Pharmacol Res. 2009 Apr;59(4):263-8. doi: 10.1016/j.phrs.2008.12.008. Epub 2008 Dec 31.
10
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?血管紧张素II 2型受体刺激:心肌梗死中对肾素-血管紧张素系统进行治疗干预的新选择?
Circulation. 2008 Dec 9;118(24):2523-32. doi: 10.1161/CIRCULATIONAHA.108.784868. Epub 2008 Nov 24.

慢病毒介导的血管紧张素-(1-7)过表达减轻缺血诱导的心脏病理生理学改变。

Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.

机构信息

Department of Pharmadocynamics, University of Florida, SW 1600 Archer Road, Gainesville, FL 32610, USA.

出版信息

Exp Physiol. 2011 Sep;96(9):863-74. doi: 10.1113/expphysiol.2011.056994. Epub 2011 Jun 17.

DOI:10.1113/expphysiol.2011.056994
PMID:21685447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3755594/
Abstract

Myocardial infarction (MI) results in cell death, development of interstitial fibrosis, ventricular wall thinning and ultimately, heart failure. Angiotensin-(1-7) [Ang-(1-7)] has been shown to provide cardioprotective effects. We hypothesize that lentivirus-mediated overexpression of Ang-(1-7) would protect the myocardium from ischaemic injury. A single bolus of 3.5 × 10(8) transducing units of lenti-Ang-(1-7) was injected into the left ventricle of 5-day-old male Sprague-Dawley rats. At 6 weeks of age, MI was induced by ligation of the left anterior descending coronary artery. Four weeks after the MI, echocardiography and haemodynamic parameters were measured to assess cardiac function. Postmyocardial infarction, rats showed significant decreases in fractional shortening and dP/dt (rate of rise of left ventricular pressure), increases in left ventricular end-diastolic pressure, and ventricular hypertrophy. Also, considerable upregulation of cardiac angiotensin-converting enzyme (ACE) mRNA was observed in these rats. Lentivirus-mediated cardiac overexpression of Ang-(1-7) not only prevented all these MI-induced impairments but also resulted in decreased myocardial wall thinning and an increased cardiac gene expression of ACE2 and bradykinin B2 receptor (BKR2). Furthermore, in vitro experiments using rat neonatal cardiac myocytes demonstrated protective effects of Ang-(1-7) against hypoxia-induced cell death. This beneficial effect was associated with decreased expression of inflammatory cytokines (tumour necrosis factor-α and interleukin-6) and increased gene expression of ACE2, BKR2 and interleukin-10. Our findings indicate that overexpression of Ang-(1-7) improves cardiac function and attenuates left ventricular remodelling post-MI. The protective effects of Ang-(1-7) appear to be mediated, at least in part, through modulation of the cardiac renin-angiotensin system and cytokine production.

摘要

心肌梗死(MI)导致细胞死亡、间质纤维化发展、心室壁变薄,最终导致心力衰竭。血管紧张素-(1-7)[Ang-(1-7)]已被证明具有心脏保护作用。我们假设慢病毒介导的 Ang-(1-7)过表达将保护心肌免受缺血损伤。将 3.5×10(8)个转导单位的 lenti-Ang-(1-7)单次注射到 5 天大的雄性 Sprague-Dawley 大鼠的左心室。在 MI 后 6 周,通过结扎左前降支冠状动脉诱导 MI。MI 后 4 周,测量超声心动图和血流动力学参数以评估心功能。心肌梗死后,大鼠的短轴缩短率和 dP/dt(左心室压力上升率)显著降低,左心室舒张末期压升高,心室肥厚。此外,这些大鼠的心脏血管紧张素转换酶(ACE)mRNA 表达也显著上调。慢病毒介导的心脏 Ang-(1-7)过表达不仅防止了所有这些 MI 引起的损伤,而且还导致心肌变薄减少和心脏 ACE2 和缓激肽 B2 受体(BKR2)的基因表达增加。此外,使用大鼠乳鼠心肌细胞的体外实验表明 Ang-(1-7)对缺氧诱导的细胞死亡具有保护作用。这种有益作用与炎症细胞因子(肿瘤坏死因子-α和白细胞介素-6)表达减少和 ACE2、BKR2 和白细胞介素-10 基因表达增加有关。我们的研究结果表明,Ang-(1-7)过表达可改善 MI 后的心功能并减轻左心室重构。Ang-(1-7)的保护作用似乎至少部分通过调节心脏肾素-血管紧张素系统和细胞因子产生来介导。